Filing Flows › Ideaya Biosciences (IDYA) › Guidance history
Ideaya Biosciences (IDYA) guidance history: what it guided and what it reported
Ideaya Biosciences gave guidance in 1 earnings release on file since Nov 3, 2026.
Net income
Every guided period is still to be reported.
| Period | Guided (and how it moved) | Reported | Result | vs midpoint |
|---|---|---|---|---|
| FY2026 | $337M (Nov 3, 2026) | — | to be reported | — |
The latest quarter
Ideaya Biosciences, Q3 2026: revenue $10.2M (-95% year over year), net loss $126M, operating cash flow −$93.5M. The chart follows the revenue to costs, profit and cash.
Questions
Does Ideaya Biosciences beat its guidance?
Ideaya Biosciences gave guidance in 1 earnings release on file since Nov 3, 2026.
Each guided period is held to the last guidance given before its figures were reported; a single figure counts as in line within 1% (0.25 pts for a rate). Reported figures are GAAP, from the company's filings; adjusted guidance shows its moves only.